A national study of older adults with multimorbidity found that surgery for acute cholecystitis reduced readmissions, emergency visits, and long-term costs compared to non-operative treatment.
In a recent clinical trial, researchers found that a reduced-dose chemoradiotherapy regimen for early-stage anal cancer may be comparable to standard treatment in achieving short-term tumor response, while causing fewer serious side effects.
May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.
A large cohort study found neoadjuvant radiotherapy improved survival for rectal cancer patients but significantly increased the risk of permanent diverting stomas—especially in upper rectal tumors.
A long-term clinical trial found that structured exercise after colon cancer treatment improved survival outcomes and reduced recurrence rates, offering evidence to support physical activity as part of survivorship care.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers analyzed over 92,000 colonoscopies and proposed a new quality metric—case-mix adjusted polyp count—that outperformed traditional benchmarks in tracking detection performance.
A new study found colon cancer patients with cannabis use disorder were more than 10 times more likely to die within five years, even after adjusting for age and disease severity.